Clinical trials
Terminated Phase 1 Lymphoma, T-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Alabama at Birmingham | 2 |
| Agios Pharmaceuticals, Inc. | 1 |
| Beijing Boren Hospital | 1 |
| Brian Hill, MD, PhD | 1 |
| CRISPR Therapeutics AG | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fred Hutchinson Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Nevada Cancer Institute | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 14 |
| Lymphoma | 6 |
| Hodgkin Disease | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Multiple Myeloma | 3 |
| Hematologic Neoplasms | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, T-Cell | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.